Vitamin D Treatment in Patients With Chronic Hepatitis C

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Chronic Hepatitis C

Treatments: Drug: Adding vitamin D; Drug: Vitamin D

Study type: Interventional

Funder types: Other

Identifiers

NCT00804752

0040-08-HYMC

Details and patient eligibility

About

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic Hepatitis C Genotype 1

Exclusion criteria

• Vitamin D intoxication Renal Failure Liver Failure Malignancy

Trial design

0 participants in 1 patient group

Vitamin D

Experimental group

Description:

An addition of Vitamin D to the standard treatment

Treatment:

Drug: Vitamin D

Drug: Adding vitamin D